Small Molecule Antagonists of the Wnt/Beta-Catenin Signaling Pathway Target Breast Tumor-Initiating Cells in a Her2/Neu Mouse Model of Breast CancerRobin Hallett, John A. Hassell|PLoS ONE|2012Cited by 93
Phase I, first-in-human study of MSC-1 (AZD0171), a humanized anti-leukemia inhibitory factor monoclonal antibody, for advanced solid tumorsErkut Borazanci, Josep Tabernero, Elena Garralda et al.|ESMO Open|2022Cited by 37
Transcript signatures that predict outcome and identify targetable pathways in MYCN‐amplified neuroblastomaRobin Hallett, Meredith S. Irwin|Molecular Oncology|2016Cited by 17